Brian Kopell, MD
img_Brian Kopell
PROFESSOR | Neurosurgery
PROFESSOR | Neurology
PROFESSOR | Psychiatry
PROFESSOR | Neuroscience
Are you a patient?
Specialties
Neurosurgery
Electrophysiological Biomarkers to Optimize Deep Brain Stimulation for Depression
The Icahn School of Medicine at Mount Sinai is running a single-center experimental trial of deep brain stimulation (DBS) to the subcallosal cingulate region (Area 25) for treatment resistant depression (TRD). The goal of this study is to refine and optimize this treatment approach using a newly available neuromodulation system (the Medtronic Summit RC+S) that allows brain activity during ongoing therapeutic DBS to be recorded from the brain in real-time. This study will further define brain readouts that track depression recovery, providing novel strategies to monitor and guide treatment and device programming decisions in patients receiving DBS for TRD.
   
Participating Mount Sinai Programs:
To enroll in the study contact Emma Meyer at 212-241-6539 or dac@mssm.edu.
For more information visit Mount Sinai Clinical Trials.


Cortical Stimulation for Tinnitus
Cortical and Deep Brain Stimulation for Depression and Obsessive Compulsive Disorder
Intraoperative Image-Guidance for Deep Brain Stimulation

MD, New York University School of Medicine

Internship, Surgery (General Surgery), NYU Medical Center

Residency, Neurosurgery, NYU Medical Center

Fellowship, Neurosurgery, Cleveland Clinic Foundation

Certifications

American Board of Neurological Surgery

2015-2019

Top Doctors - New York Metro Area

Castle Connolly

To Dream Again
Deep Brain Stimulation Surgery to treat Parkinson's Disease at Mount Sinai Hospital